NCT02237339View on ClinicalTrials.gov

Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension?

PHASE4CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
HypertensionHypertrophy, Left Ventricular
Interventions
DRUG

Allopurinol

Uric acid lowering medication.

DRUG

Placebo

Trial Locations (1)

DD1 9SY

University of Dundee, Ninewells Hospital, Dundee

All Listed Sponsors
collaborator

British Heart Foundation

OTHER

lead

University of Dundee

OTHER

NCT02237339 - Does Allopurinol Reduce Thickening of the Left Ventricle of the Heart in Patient With Treated Hypertension? | Biotech Hunter | Biotech Hunter